Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01967446 · ClinicalTrials.gov registry record

Predictors of Post Operative Morbidity in Older Women With Pelvic Organ Prolapse

A clinical trial of Pelvic Organ Prolapse, sponsored by University of Pennsylvania.

Completed
Registry status
132
Enrollment target
1
Study location

NCT01967446 is a study of Pelvic Organ Prolapse that has completed, run by University of Pennsylvania. The registered enrollment target is 132 participants, roughly in line with the 142-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01967446, a study of Pelvic Organ Prolapse, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
132 participants
Enrollment target
1
Study location

Study Summary

The Investigators hypothesize that functional status scores in elderly women undergoing surgery for pelvic organ prolapse will be lower at 6 weeks post-operatively but will have returned to baseline at 12 weeks post-operatively. The Investigators hypothesize that greater co-morbidity, frailty and worse functional status before surgery are associated with slower functional recovery, prolonged length of stay in a hospital or nursing care institution and greater post-operative complications following surgery for pelvic organ prolapse.

Conditions Studied

Study Locations (1)

Pennsylvania

  • Hospital of the University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 132 participants
Start Date 2012-03
Est. Completion 2013-07

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT01967446

The ClinicalTrials.gov registry entry for NCT01967446 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 142-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pelvic Organ Prolapse appearing as the primary indexed condition, and to 0 interventions.

NCT01967446 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01967446 about?

NCT01967446 is a clinical study titled "Predictors of Post Operative Morbidity in Older Women With Pelvic Organ Prolapse". The Investigators hypothesize that functional status scores in elderly women undergoing surgery for pelvic organ prolapse will be lower at 6 weeks post-operatively but will have returned to baseline at 12 weeks post-operatively. The Investigators hypothesize that greater co-morbidity, frailty and w...

What is the current status of trial NCT01967446?

This trial is currently completed. The enrollment target is 132 participants. The study started on 2012-03. Estimated completion is 2013-07.

What conditions does trial NCT01967446 study?

This clinical trial studies the following conditions: Pelvic Organ Prolapse.

Who is sponsoring clinical trial NCT01967446?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01967446 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pelvic Organ Prolapse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.